CAM
MEDP icon

Congress Asset Management’s Medpace MEDP Stock Holding History

Congress Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31M Sell
58,479
-1,708
-3% -$788K 0.19% 129
2026
Q1 		$28.9M Sell
60,187
-191
-0.3% -$97.8K 0.21% 125
2025
Q4 		$33.9M Sell
60,378
-4,317
-7% -$2.45M 0.24% 117
2025
Q3 		$33.3M Buy
64,695
+7,190
+13% +$3.14M 0.22% 118
2025
Q2 		$18M Buy
57,505
+2,517
+5% +$756K 0.12% 145
2025
Q1 		$16.8M Buy
54,988
+1,292
+2% +$435K 0.13% 147
2024
Q4 		$17.8M Buy
53,696
+6,878
+15% +$2.33M 0.12% 143
2024
Q3 		$15.6M Sell
46,818
-2,519
-5% -$957K 0.11% 149
2024
Q2 		$20.3M Sell
49,337
-106,069
-68% -$42M 0.15% 127
2024
Q1 		$62.8M Buy
155,406
+2,012
+1% +$707K 0.45% 82
2023
Q4 		$47M Buy
153,394
+5,819
+4% +$1.57M 0.37% 87
2023
Q3 		$35.7M Buy
147,575
+12,317
+9% +$3.15M 0.32% 86
2023
Q2 		$32.5M Buy
135,258
+22,803
+20% +$4.74M 0.28% 89
2023
Q1 		$21.1M Buy
112,455
+1,658
+1% +$343K 0.2% 104
2022
Q4 		$23.5M Sell
110,797
-2,306
-2% -$461K 0.24% 89
2022
Q3 		$17.8M Buy
113,103
+7,444
+7% +$1.19M 0.19% 96
2022
Q2 		$15.8M Sell
105,659
-617
-0.6% -$89.3K 0.15% 106
2022
Q1 		$17.4M Buy
106,276
+27,087
+34% +$4.47M 0.15% 98
2021
Q4 		$17.2M Buy
79,189
+5,904
+8% +$1.24M 0.13% 100
2021
Q3 		$13.9M Buy
73,285
+1,620
+2% +$295K 0.11% 110
2021
Q2 		$12.7M Buy
71,665
+1,046
+1% +$181K 0.11% 110
2021
Q1 		$11.6M Buy
70,619
+4,796
+7% +$734K 0.1% 110
2020
Q4 		$9.16M Buy
65,823
+3,391
+5% +$427K 0.09% 134
2020
Q3 		$6.98M Sell
62,432
-948
-1% -$110K 0.08% 144
2020
Q2 		$5.9M Buy
63,380
+8,942
+16% +$761K 0.07% 142
2020
Q1 		$4M Buy
54,438
+11,740
+27% +$1.02M 0.06% 164
2019
Q4 		$3.59M Buy
42,698
+2,715
+7% +$210K 0.04% 204
2019
Q3 		$3.36M Buy
+39,983
New +$3.02M 0.04% 225

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Congress Asset Management's MEDP Position: Q2 2026 in Review

Congress Asset Management reduced its Medpace (MEDP) stake by 2.8% in Q2 2026, selling an estimated $788K and leaving 58,479 shares worth $31M. The position accounts for 0.19% of the portfolio, ranked #129.

Congress Asset Management first reported a position in MEDP in Q3 2019 and has held it in 28 quarters since. The position peaked at $62.8M in Q1 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Congress Asset Management held 58,479 shares of Medpace worth $31M as of Q2 2026.
  • Congress Asset Management sold 1,708 Medpace shares in Q2 2026, an estimated $788K.
  • Medpace made up 0.19% of Congress Asset Management's portfolio in Q2 2026, its #129 holding.
  • Congress Asset Management first reported a position in Medpace in Q3 2019 and has held it in 28 quarters since.
  • Congress Asset Management's Medpace position peaked at $62.8M in Q1 2024.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.